Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.52 |
| ▸ | SELP | P16109 | 1/20 | 0.48 |
| ▸ | P2RY10 | O00398 | 6/20 | 0.47 |
| ▸ | GPR34 | Q9UPC5 | 1/20 | 0.47 |
| ▸ | FABP3 | P05413 | 1/20 | 0.47 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.43 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31468233 | 1.00 | PLA2G2C (0.52) | PLA2G2CSELPP2RY10GPR34FABP3 | |
| SCHEMBL30094354 | 1.00 | PLA2G2C (0.52) | PLA2G2CSELPP2RY10GPR34FABP3 | |
| SCHEMBL19595704 | 1.00 | PLA2G2C (0.52) | PLA2G2CSELPP2RY10GPR34FABP3 | |
| SCHEMBL29985298 | 0.93 | SELP (0.46) | PLA2G2CSELPP2RY10GPR34FABP3 | |
| SCHEMBL1296680 | 0.93 | PLA2G2C (0.49) | PLA2G2CSELPP2RY10GPR34FABP3 | |
| SCHEMBL1296985 | 0.93 | PLA2G2C (0.49) | PLA2G2CSELPP2RY10GPR34FABP3 | |
| SCHEMBL25252924 | 0.92 | PLA2G2C (0.48) | PLA2G2CSELPP2RY10GPR34FABP3 | |
| SCHEMBL30976336 | 0.92 | PLA2G2C (0.48) | PLA2G2CSELPP2RY10GPR34FABP3 | |
| SCHEMBL235778 | 0.92 | PLA2G2C (0.48) | PLA2G2CSELPP2RY10GPR34FABP3 | |
| SCHEMBL31318032 | 0.92 | PLA2G2C (0.48) | PLA2G2CSELPP2RY10GPR34FABP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115197079-A | Polyethylene glycol lipid and liposome modified by same, pharmaceutical composition containing liposome, preparation and application of pharmaceutical composition | 厦门赛诺邦格生物科技股份有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-115197080-A | Polyethylene glycol lipid and liposome modified by same, pharmaceutical composition containing liposome, preparation and application of pharmaceutical composition | 厦门赛诺邦格生物科技股份有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-115197079-A | Polyethylene glycol lipid and liposome modified by same, pharmaceutical composition containing liposome, preparation and application of pharmaceutical composition | 厦门赛诺邦格生物科技股份有限公司 | 2022-10-18 | — | — | CN | disclosed |
| CN-115197080-A | Polyethylene glycol lipid and liposome modified by same, pharmaceutical composition containing liposome, preparation and application of pharmaceutical composition | 厦门赛诺邦格生物科技股份有限公司 | 2022-10-18 | — | — | CN | disclosed |
| CN-115197078-A | Polyethylene glycol lipid and liposome modified by same, pharmaceutical composition containing liposome, preparation and application of pharmaceutical composition | 厦门赛诺邦格生物科技股份有限公司 | 2022-10-18 | — | — | CN | disclosed |